CURIA GLOBAL INC

Curia Global Inc. specializes in end-to-end pharmaceutical and life sciences R&D services, with deep expertise in medicinal chemistry, compound synthesis, and analytical characterization. The company delivers hit-to-lead optimization, ADMET profiling, X-ray crystallography, and GMP/non-GMP synthesis for small molecule therapeutics, supporting drug discovery pipelines from early-stage screening to preclinical development. Their technical capabilities include structural biology, molecular characterization, and stability testing of complex pharmaceutical candidates, with demonstrated proficiency in supporting NIH and NCATS initiatives through high-precision laboratory services. Curia differentiates itself through agile, mission-focused execution in support of government-funded therapeutic programs, particularly in infectious disease and neurotherapeutics. The contractor maintains a consistent, long-standing relationship with the Department of Health and Human Services, primarily serving agencies such as the National Institutes of Health and the Biomedical Advanced Research and Development Authority. Work performed includes supporting exploratory chemistry projects, nonclinical development of intervention agents, and analytical validation for novel compounds, often under time-sensitive, high-impact research initiatives. There is no evidence of significant engagement with other federal entities beyond HHS. Curia’s primary focus lies in NAICS 541715 (physical, engineering, and life sciences R&D) and 541380 (testing laboratories), with complementary activity in pharmaceutical manufacturing (325412). This positions them as a niche provider bridging early-stage discovery and preclinical development, serving government-funded biopharma programs that require integrated chemistry, analytics, and formulation services without commercial scale-up. Their work is centered on small molecule drug candidates, with emphasis on structural analysis and pharmacokinetic profiling. Curia Global Inc. is a small business entity headquartered in Albany, NY, with no federal certifications on record. The company operates as a specialized technical services provider within the federal life sciences ecosystem, leveraging its geographic proximity to academic and research institutions to support mission-critical government R&D programs.